ArticleCroatian medical journal2022

Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients.

Snježana Ramić et al.PubMed ↗Full text ↗

No numbers read from the abstract.